AbbVie and MBC BioLabs invite entrepreneurial scientists and founders to apply for a 2018 AbbVie Golden Ticket. The AbbVie Golden Ticket provides a year’s use of a lab bench and core facilities at MBC BioLabs’ San Francisco or San Carlos site, as well as opportunities to engage with AbbVie scientific and business leaders. It will be awarded to an early stage company developing novel, transformational therapies for autoimmune, oncology, or neurodegenerative disease.
To apply, please email your non-confidential company presentation to GoldenTicket@abbvie.com
by Friday, March 2, 2018.
In the application, please address:
- What is the scientific insight and approach driving your company?
- If successful, how would your therapeutic approach provide significant patient benefit beyond currently available treatment or other R&D stage programs?
- How will a Golden Ticket impact your company’s aims?
- When would you like to start using the space?
Selected applicants will be invited to present their company to a select group of AbbVie leadership at an event to be held at MBC BioLabs in April.